Study shows that anti-parasitic drug slows pancreatic cancer in mice
Florida board reverses mask mandate, complies with DeSantis
3 August 2021Serum aldosterone in patients with heart failure with a preserved ejection fraction
3 August 2021Study shows that anti-parasitic drug slows pancreatic cancer in mice
As the third-most lethal cancer in the United States, with only a 1% five-year survival rate for people with its most aggressive form, pancreatic cancer has long been a target of researchers who search for ways to slow or stop its growth and spread. Now, a team of Johns Hopkins Medicine researchers have found that an anti-parasitic drug prevents pancreatic cancer’s initiation, progression and metastasis in genetically engineered mice.
